Characteristics and risk factors associated with death during tuberculosis treatment among new patients with pulmonary tuberculosis in the Upper North of Thailand, year 2005-2014

  • เจริญศรี แซ่ตั้ง Office of Disease Prevention and Control Region 1, Chiang Mai, Department of Disease Control
Keywords: tuberculosis, death, risk factor

Abstract

Tuberculosis (TB) remains the public health problem of Thailand. More than 5,000 cases/year were reported success rate was 70.0-75.0% due to death during treatment. This study aimed to analyze the risk factors associated death among new pulmonary tuberculosis patients. It is retrospective study, new pulmonary TB cases who registered at TB clinic of public health hospitals in 8 provinces in the Upper North Thailand. Treatment outcome were reported by TB-Clinic with case management (TBCM) which is the electronic for TB recording in the hospital of Thailand from 2005 to 2014. Statistic analysis was relatives risk by univariate analysis, p<0.05. Of the 39,533 cases, male 71.3%, age >50 years 68.6%, HIV positive 13.6%, comorbidity diseases 10.5%. 33,521 cases survived (84.8%) and death 6,012 cases (15.2%). The risk factors of death were age >50 years (19.3%) (RR1.9, 95% CI 1.8-2.0), HIV positive (27.1%) (RR 2.4, 95% CI 2.3-2.6), patients with comorbidity diseases such hypertension, diabetes mellitus, COPD, renal disease, liver disease and cancer (21.3%) (RR 1.5, 95% CI 1.4-1.6). Among comorbidity diseases, diseases risk were hypertension (19.7%) (RR 1.3, 95% CI 1.2-1.5), COPD (32.2%) (RR 2.2, 95% CI 2.0-2.4), renal disease (41.8%) (RR 2.8, 95% CI 2.4-3.2), liver diseases (38.5%) (RR 2.5, 95% CI 2.0-3.2) and cancer (RR 3.5, 95% CI 2.8-4.5) (p<0.05). Conclusion the HIV positive patient was the strongest risk of death during treatment (33.3%) and aging patient ranks the second (68.6%). More concern on patients with comorbidity diseases have to be taken in to consideration to lower the risk of TB death.

Downloads

Download data is not yet available.

References

1. สำนักวัณโรค. แนวทางการดำเนินงานควบคุมวัณโรค แห่งชาติ พ.ศ. 2556. กรุงเทพมหานคร: ชุมนุมสหกรณ์ การเกษตรแห่งประเทศไทย; 2556.

2. World Health Organization. Global tuberculosis report 2015. France: World Health Organiza¬tion; 2015.

3. กลุ่มพัฒนาภาคีเครือข่าย งานวัณโรค. รายงาน สถานการณ์วัณโรคเขต 1 เชียงใหม่. เชียงใหม่: สำนักงานป้องกันควบคุมโรคที่ 1 จังหวัดเชียงใหม่; 2559.

4. Lin CH, Lin CJ, Kuo YW, Wang JY, Hsu CL, Chen JM, et al. Tuberculosis mortality: patient characteristics and causes. BMC Infect Dis 2014;14:5.

5. World Health Organization. Noncommunicable diseases country profiles 2011. Geneva: World Health Organization; 2011.

6. Horne DJ, Hubbard R, Narita M, Exarchos A, Park DR, Goss CH. Factors associated with mortality in patients with tuberculosis. BMC Infect Dis 2010;10:258.

7. Velásquez GE, Cegielski JP, Murray MB, Yagui MJ, Asencios LL, Bayona JN, et al. Impact of HIV on mortality among patients treated for tuberculosis in Lima, Peru: a prospective cohort study. BMC Infect Dis 2016;16:45.

8. Low S, Ang LW, Cutter J, James L, Chee CB, Wang YT, et al. Mortality among tuberculosis patients on treatment in Singapore. Int J Tuberc Lung Dis 2009;13:328-34.

9. Moolphate S, Aung MN, Nampaisan O, Nedsuwan S, Kantipong P, Suriyon N, et al. Time of highest tuberculosis death risk and associated factors: an observation of 12 years in Northern Thailand. Int J Gen Med 2011;4:181-90.

10. Shen X, DeRiemer K, Yuan Za, Shen M, Xia Z, Gui X, et al. Deaths among tuberculosis cases in Shanghai, China: who is at risk?. BMC Infect Dis 2009;9:95.

11. Tessema B, Muche A, Bekele A, Reissig D, Emmrich F, Sack U. Treatment outcome of tuberculosis patients at Gondar University Teaching Hospital, Northwest Ethiopia. A five-- year retrospective study. BMC Public Health 2009;9:371.

12. Lönnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 2009;68:2240-6.

13. TB CARE I, UNAIDS. International standards for tuberculosis care, 3rd ed. Hague, Netherlands: TB CARE I; 2014.

14. Moolphate S, Aung MN, Nampaisan O, Nedsu¬wan S, Kantipong P, Suriyon N, et al. Time of highest tuberculosis death risk and associated factors: an observation of 12 years in Northern Thailand. Int Journal Gen Med 2011;4:181- 90.

15. Jayawardena K, Samarathunga M. Baseline characteristics of patients and the effect of fixed-dose combination chemotherapy on sputum conversion time in active pulmonary tuberculosis: a preliminary study in Kandy District, Sri Lanka. SAARC J Tuber Lung Dis HIV/AIDS 2008; 5:1-6.

16. Alobu I, Oshi SN, Oshi DC, Ukwaja KN. Risk factors of treatment default and death among tuberculosis patients in a resource-limited setting. Asian Pac J Trop Med 2014;7:977-84.

17. Wang JY, Lee LN, Yu CJ, Chien YJ, Yang PC, Tami Group. Factors influencing time to smear conversion in patients with smear‐positive pulmonary tuberculosis. Respirology 2009;14: 1012-9.

18. Nahid P, Jarlsberg LG, Rudoy I, de Jong BC, Unger A, Kawamura LM, et al. Factors associ¬ated with mortality in patients with drug-suscep¬tible pulmonary tuberculosis. BMC Infec Dis 2011;11:1.

19. Jianzhao H, van den Hof S, Lin X, Yubang Q, Jinglong H, van der Werf MJ. Risk factors for non-cure among new sputum smear positive tuberculosis patients treated in tuberculosis dispensaries in Yunnan, China. BMC Health Serv Res 2011;11:97.

20. Dooley KE, Lahlou O, Ghali I, Knudsen J, Elmessaoudi MD, Cherkaoui I, et al. Risk factors for tuberculosis treatment failure, default, or relapse and outcomes of retreatment in Morocco. BMC Public Health. 2011;11:140.

21. H Simon Schaaf, Alimuddin I Zumla, Tuberculosis: a comprehensive clinical reference. In: Nachega JB, editor. Clinical aspects of tuberculsis in HIV-infected adults. World Health Organization: Regional Office for South-East Asia; 2009. p. 524-31.

22. Kwan CK, Ernst JD. HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev 2011;24:351-76.

23. Singhal S, Jaiswa P. Presentation of tuberculosis in TB-HIV co-infection patients and the treatment outcome with directly observed short course therapy. Asian Pac J Trop Biomed 2011;1:S266-7.

24. Jonnalagada S, Harries AD, Zachariah R, Satyanarayana S, Tetali S, Chander GK, et al. The timing of death in patients with tuberculosis who die during anti-tuberculosis treatment in Andhra Pradesh, South India. BMC Public Health 2011;11:921.

25. Inghammar M, Ekbom A, Engström G, Ljung¬berg B, Romanus V, Lofdahl C-G, et al. COPD and the risk of tuberculosis--a population-based cohort study. PloS One 2010;5:e10138.
Published
2017-12-29
Section
Original Article